back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-06-22 20:25 Tx date 2022-06-15 |
$ENER
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Druker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
129,200 | ||
| Filed 2022-06-22 20:25 Tx date 2022-06-15 |
$ENER
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Druker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,230,000 | ||
| Filed 2021-09-05 05:43 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Druker, Yoram
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$295,000
+500,000 vol $0.59 each |
2,660,000 | |
| Filed 2020-06-17 08:37 Tx date 2020-06-11 |
$INNO
InnoCan Pharma Corporation |
Druker, Yoram
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+410,000 vol |
2,160,000 | |
| Filed 2019-10-06 03:17 Tx date 2019-09-25 |
$
InnoCan Pharma Corporation |
Druker, Yoram
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,750,000 | ||
| Filed 2019-10-03 11:28 Tx date 2019-09-25 |
$
InnoCan Pharma Corporation |
Druker, Yoram
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
12,201,000 |